FDA Warns of Clip Lock Malfunctions With Abbott''s MitraClip Heart Valve Devices
The FDA alerted healthcare providers about the potential for clip lock malfunctions with Abbott Laboratories (NYSE: ABT ) MitraClip''s delivery system to stop heart valve leakage. "These events appear to occur in approximately 1.3% of MitraClip procedures and have been observed with all device models," the FDA said in a letter . The MitraClip device was approved in 2013 for patients with symptomatic, degenerative mitral regurgitation (MR) deemed high risk for mitral-valve surgery. In its own … Full story available on Benzinga.com
FDA Warns of Clip Lock Malfunctions With Abbott''s MitraClip Heart Valve Devices
The FDA alerted healthcare providers about the potential for clip lock malfunctions with Abbott Laboratories (NYSE: ABT ) MitraClip''s delivery system to stop heart valve leakage. "These events appear to occur in approximately 1.3% of MitraClip procedures and have been observed with all device models," the FDA said in a letter . The MitraClip device was approved in 2013 for patients with symptomatic, degenerative mitral regurgitation (MR) deemed high risk for mitral-valve surgery. In its own … Full story available on Benzinga.com